Outsourcing STREAM
-
Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility
10/7/2022
Bionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future.
-
Release Your Gene Therapy With Confidence
7/20/2021
You are developing a cell or gene therapy and now you need to deliver it quickly to patients. But first you must make sure it's safe and effective. That's where we come in. Our experts can draw a testing strategy for your specific product, process, and goals.
-
MilliporeSigma Capacity Update October 2025: ADC
7/28/2025
MilliporeSigma and Simtra's streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill/finish of drug substance.
-
Building Resilience In Biomanufacturing Operations
2/5/2026
In this segment from the Bioprocess Online Live event, “Protecting Bioprocessing Operations and Supply Chains In A Turbulent Economy,” panelists share their thoughts on what it means to be resilient and how organizations can embody resilience in their biomanufacturing, which in part requires agility and preparation for the worst-case scenario. The panel was in agreement that earlier-phase companies have the highest opportunity to bake resilience into their operations.
-
Take A Virtual Tour Of Our Cell Line Development Centre Of Excellence
9/8/2025
Explore the advanced capabilities of our Cell Line Development Center in Ulm, Germany. From expert teams to streamlined processes, discover how we support biopharma innovation.
-
Microbiology Testing Systems Maintenance & Repair Services Plans
10/8/2024
Watch to learn about microbiology testing systems maintenance and repair services plans from a company with proven expertise.
-
How Will U.S. Tariffs And The BIOSECURE Act Impact Global Biopharma Markets?
2/5/2026
In this segment from the Bioprocess Online Live event, “Protecting Bioprocessing Operations and Supply Chains In A Turbulent Economy,” panelists explain how tariffs imposed by the U.S. are putting competitive pressure on companies to reduce COGs. They also discuss the short- to long-term impact of efforts to onshore biomanufacturing.
-
Selecting The Right CMO For Your Gene Therapy
5/15/2020
Find out what criteria makes a great CMO partner and how to know if it is the right one for your gene therapy.
-
Building LEO Pharma's U.S. Presence with Brian Hilberdink
8/23/2023
In many respects, bringing an established foreign biopharma company to the U.S. market is not unlike starting one up from scratch. In other respects, it's even harder. The job's not for the faint of heart, which might be why the Danish company LEO Pharma tapped veteran biopharma leader Brian Hilberdink to lead its U.S. operations.
-
ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients
6/7/2022
The ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients is the most commonly referenced quality guideline in pharmaceutical product and contains five segments. Watch the video to learn more.